AzTrials
AzTrials

Consciousness DisorderNCT05802524

Neurophysiological Evaluation of Residual Cognitive Functions in Patients With Severe Alterations of Consciousness

An observational study of Consciousness Disorder and Cognitive Impairment, run by IRCCS Centro Neurolesi Bonino Pulejo at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Identify potential markers of recovery through event-related potentials (ERPs) in the evolution of altered consciousness with potential ability to discriminate between different conditions of altered state of consciousness. Read more about this study

Who is it for?
Any age
Conditions the study is for
Consciousness Disorder, Cognitive Impairment
What is being tested?
Neurowave Group
How many people
20 participants
Where
1 siteItaly
Study dates
14 Jun 2020to 14 Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Departments of Serious Acquired Brain Injuries

Who may be able to join

  • Glasgow Coma Scale (GCS) > 8;
  • Level of Cognitive Scale (LCF) = 1-3;
  • Signature of the consent from the family member and/or guardian.

Who cannot join

  • Failure to sign the consent of the family member and/or legal guardian;
  • Patients with cranial anatomical alterations that do not allow the correct assembly of the electrodes, caps, etc.;
  • Patients with absence of neurophysiological responses in visual evoked potentials (VEP) and with absence of peripheral waves (I-II wave) to acoustic potentials (PEA).

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Centro Neurolesi "Bonino-Pulejo"

    Messina, 98124

Other trials in Italy

About this study

Official title: Neurophysiological Approach for the Evaluation of Residual Cognitive Functions in Patients With Severe Alterations of Consciousness

Identify potential markers of recovery through event-related potentials (ERPs) in the evolution of altered consciousness with potential ability to discriminate between different conditions of altered state of consciousness.

Identify potential markers with prognostic value, in order to identify personalized and specific intensive rehabilitation paths based on the outcome indexes obtained.

Being tested
Neurowave Group
Medical subject headings
Consciousness Disorders, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neurowave GroupDiagnostic test

    Neurosensory stimulation will consist in the administration of pairs of stimuli consisting of emotionally significant images and sounds in the personal life history (two rare stimuli) alternating with neutral images and sounds devoid of emotional significance (two "distracting" stimuli

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Event-related evoked potentials(ERPs)

    Event-related evoked potentials(ERPs) are variations of the electric potential deriving from a visual, somesthetic or auditory stimulus.

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2023
  2. Study start14 Jun 2020
  3. Primary completion1 Jun 2022
  4. Study completion14 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05802524
Sponsor's protocol ID
Multi-NW
Status last verified
Mar 2023
First submitted
15 Mar 2023
Last updated
6 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: corresponding author

Questions about this trial

What is this clinical trial studying?

An observational study of Consciousness Disorder and Cognitive Impairment, run by IRCCS Centro Neurolesi Bonino Pulejo at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Event-related evoked potentials(ERPs) (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in